Posted April 22nd, 2017.
Novavax (NASDAQ:NVAX) develops vaccines based on protein nanoparticles which can help increase the immune response in patients. It is currently awaiting results of phase 3 trial. A successful result will provide significant bump to the stock and also make it an attractive acquisition target by bigger pharmaceutical companies. RSV F...
Posted April 18th, 2017.
DryShips (NASDAQ:DRYS) has had a rough run in the past few weeks. The stock price has declined by over three quarters in the last one month. However this rapid decline in the stock price hides the strong key metrics which the company boasts. The company has a number of drybulk carriers and offshore vessels which provide transportation of...